Skip to main content
Premium Trial:

Request an Annual Quote

Bank Upgrades Sigma-Aldrich Stock

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Robert W. Baird has upped its rating on Sigma-Aldrich's stock to "outperform" from "neutral," a day after the firm beat Wall Street expectations for fourth-quarter revenues and net income.

The St. Louis-based chemicals and research tools provider reported 12 percent revenue growth year over year to $572.5 million, beating analysts' consensus estimate of $561 million. The company also said that it expects 2010 organic revenue growth in the mid-single digits.

Baird Analyst Quintin Lai said the he expects Sigma-Aldrich to report revenue growth of around 6 percent to $2.29 billion. Analysts, on average, expect the firm to report revenues of $2.31 billion.

Lai placed a price target of $60 per share on Sigma-Aldrich's stock.

In mid-afternoon trade Thursday on the Nasdaq, shares of the firm were up 2 percent at $49.21.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.